Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II
Authors not listed
MD Stem Cells · 2016
Abstract
This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-08 MST
Cite this
APA
Anonymous. (2016). Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II. <em>MD Stem Cells</em>. https://clinicaltrials.gov/study/NCT03011541
Vancouver
Anonymous. Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II. MD Stem Cells. 2016.
BibTeX
@misc{anon2016BoneMa,
title = {Bone Marrow Derived Stem Cell Ophthalmology Treatment Study II},
author = {Anonymous},
journal = {MD Stem Cells},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
MD Stem Cells 2016
Open access · US-GOV
Neurologic Bone Marrow Derived Stem Cell Treatment Study
Progress in Retinal and Eye Research 2016
Preprint · OA
Advances in bone marrow stem cell therapy for retinal dysfunction
Advances in experimental medicine and biology 2023
Preprint · OA
Hematopoietic Stem Cells and Their Bone Marrow Niches
Leukemia 2007
Preprint · OA
Bone marrow mesenchymal stem cells are abnormal in multiple myeloma
The Foundation for Orthopaedics and Regenerative Medicine 2022
Open access · US-GOV
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cell Intravenous Infusion for the Treatment of Aging Frailty
Bone 2019
Preprint · OA